ILUNOCITINIB
UNII N3TB5AH8B9

Substance Identification & Data

This profile provides standardized clinical and technical data for Ilunocitinib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) N3TB5AH8B9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1187594-14-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

N3TB5AH8B9

CAS Registry Number

1187594-14-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ILUNOCITINIB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

N3TB5AH8B9

The specific atomic composition represented as a molecular structure string.

InChIKey

C17H17N7O2S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

RVOUEXFKIYNODQ-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C180647

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

44231134

Unique identification number in the NCBI database of chemical substances.

INN ID

11894

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

HI-157

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C(C#N)C1(CN(C1)S(=O)(=O)C2CC2)n3cc(cn3)-c4c5c(ncn4)[nH]cc5

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ilunocitinib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.